GLP-1 based therapies: clinical implications for gastroenterologists
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 based therapies: clinical implications for gastroenterologists
Authors
Keywords
-
Journal
GUT
Volume 65, Issue 4, Pages 702-711
Publisher
BMJ
Online
2016-02-15
DOI
10.1136/gutjnl-2015-310572
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
- (2015) Jacqueline A. Koehler et al. Cell Metabolism
- Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes
- (2015) Jennifer S. ten Kulve et al. DIABETES CARE
- Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1
- (2015) Mark P. Plummer et al. DIABETES CARE
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
- (2015) An Tang et al. DIABETES CARE
- Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
- (2015) Hiroyuki Kato et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Incretin-based therapies: where will we be 50 years from now?
- (2015) Juris J. Meier et al. DIABETOLOGIA
- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2015) Silvio E. Inzucchi et al. DIABETOLOGIA
- Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment
- (2015) Patrick Berg et al. DIGESTIVE DISEASES AND SCIENCES
- Relationships of Early And Late Glycemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test
- (2015) Chinmay S. Marathe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
- (2015) Feng Sun et al. Journal of Diabetes Research
- Once-weekly DPP-4 inhibitors: do they meet an unmet need?
- (2015) André J Scheen Lancet Diabetes & Endocrinology
- Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans
- (2014) C. Xiao et al. DIABETES
- The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
- (2014) C. F. Gotfredsen et al. DIABETES
- Glucagon-Like Peptide 1 Attenuates the Acceleration of Gastric Emptying Induced by Hypoglycemia in Healthy Subjects
- (2014) Mark P. Plummer et al. DIABETES CARE
- Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
- (2014) Itamar Raz et al. DIABETES CARE
- Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies
- (2014) S. Bonner-Weir et al. DIABETES OBESITY & METABOLISM
- Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway
- (2014) H. Zhao et al. DIABETES OBESITY & METABOLISM
- Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis
- (2014) Yun-A. Jung et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk of pancreatitis in patients treated with incretin-based therapies
- (2014) Juris J. Meier et al. DIABETOLOGIA
- Characterization of the Exocrine Pancreas in the Male Zucker Diabetic Fatty Rat Model of Type 2 Diabetes Mellitus Following 3 Months of Treatment With Sitagliptin
- (2014) Thomas Forest et al. ENDOCRINOLOGY
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes
- (2014) S Temizkan et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
- (2014) Yuichiro Eguchi et al. HEPATOLOGY RESEARCH
- Effects of Exogenous Glucagon-Like Peptide-1 on the Blood Pressure, Heart Rate, Mesenteric Blood Flow, and Glycemic Responses to Intraduodenal Glucose in Healthy Older Subjects
- (2014) Laurence G. Trahair et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle
- (2014) Antonella Amato et al. JOURNAL OF ENDOCRINOLOGY
- Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
- (2014) Amy G. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
- (2014) L. Li et al. BMJ-British Medical Journal
- One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice
- (2013) Kathryn Aston-Mourney et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty
- (2013) Astrid Plamboeck et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Increased Risk of Colorectal Cancer After Obesity Surgery
- (2013) Maryam Derogar et al. ANNALS OF SURGERY
- Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
- (2013) Daniel J. Drucker et al. Annual Review of Physiology
- Molecular mechanisms of incretin hormone secretion
- (2013) Marina Ezcurra et al. CURRENT OPINION IN PHARMACOLOGY
- Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
- (2013) A. E. Butler et al. DIABETES
- Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
- (2013) B. A. Aulinger et al. DIABETES
- Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia
- (2013) M. M. Umapathysivam et al. DIABETES
- Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
- (2013) C. S. Marathe et al. DIABETES CARE
- Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
- (2013) K. Hermansen et al. DIABETES OBESITY & METABOLISM
- A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
- (2013) D. Funch et al. DIABETES OBESITY & METABOLISM
- A low-grade increase of serum pancreatic exocrine enzyme levels by dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes
- (2013) Hirotake Tokuyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- An Analysis of Characteristics of Subjects Examined for Incretin Effects on Pancreatic Pathology
- (2013) Evis Harja et al. Diabetes Technology & Therapeutics
- Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
- (2013) M. A. Nauck et al. DIABETOLOGIA
- Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
- (2013) J. H. Ellenbroek et al. DIABETOLOGIA
- Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
- (2013) L van Bloemendaal et al. JOURNAL OF ENDOCRINOLOGY
- Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
- (2013) Thomas Klein et al. Medical Molecular Morphology
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia
- (2013) Martin Lorenz et al. REGULATORY PEPTIDES
- Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study
- (2013) K.B. Madsen et al. REGULATORY PEPTIDES
- Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis
- (2013) Shunya Mimura et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study
- (2013) Carlo B Giorda et al. Lancet Diabetes & Endocrinology
- The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study
- (2012) J. E. Stevens et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis
- (2012) Niels Vrang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome
- (2012) Michael Camilleri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans
- (2012) Changting Xiao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of Buspirone, a Fundus-Relaxing Drug, in Patients With Functional Dyspepsia
- (2012) Jan Tack et al. Clinical Gastroenterology and Hepatology
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- The Human GLP-1 Analog Liraglutide and the Pancreas
- (2012) Niels C.B. Nyborg et al. DIABETES
- No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks
- (2012) K. Tatarkiewicz et al. DIABETES OBESITY & METABOLISM
- Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man
- (2012) S. J. Busch et al. DIABETES OBESITY & METABOLISM
- Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight
- (2012) J. Jelsing et al. DIABETES OBESITY & METABOLISM
- Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study
- (2012) M. Wenten et al. DIABETIC MEDICINE
- Direct effect of GLP-1 infusion on endogenous glucose production in humans
- (2012) M. Seghieri et al. DIABETOLOGIA
- Erratum to: Dipeptidyl Peptidase 4-Deficient Rats Have Improved Bile Secretory Function in High Fat Diet-Induced Steatosis
- (2012) Shani Ben-Shlomo et al. DIGESTIVE DISEASES AND SCIENCES
- Elevated Amylase and Lipase Levels in Patients Using Glucagonlike Peptide-1 Receptor Agonists or Dipeptidyl-Peptidase-4 Inhibitors in the Outpatient Setting
- (2012) Howard Lando et al. Endocrine Practice
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis
- (2012) Feng Sun et al. Experimental Diabetes Research
- Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis
- (2012) Hannelouise Kissow et al. GUT
- Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion
- (2012) A Rotondo et al. INTERNATIONAL JOURNAL OF OBESITY
- Sitagliptin Exerts an Antinflammatory Action
- (2012) Antoine Makdissi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
- (2012) Daniel J. Cuthbertson et al. PLoS One
- GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
- (2012) Edwin T. Parlevliet et al. PLoS One
- Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
- (2012) Jutta Keller et al. REGULATORY PEPTIDES
- The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
- (2012) Takamasa Ohki et al. TheScientificWorldJOURNAL
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- A cohort study of acute pancreatitis in relation to exenatide use
- (2011) D. D. Dore et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
- (2011) A. E. Hogan et al. DIABETOLOGIA
- Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
- (2011) Chinmay S. Marathe et al. Experimental Diabetes Research
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
- (2011) Tomoyuki Iwasaki et al. HEPATO-GASTROENTEROLOGY
- Exenatide Exerts a Potent Antiinflammatory Effect
- (2011) Ajay Chaudhuri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
- (2011) Gianluca Svegliati-Baroni et al. LIVER INTERNATIONAL
- Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome
- (2011) D. Kunkel et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
- (2011) Scott E. Kanoski et al. NEUROPHARMACOLOGY
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
- (2010) Krystyna Tatarkiewicz et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
- (2010) Vanessa Souza-Mello et al. CLINICAL SCIENCE
- Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats
- (2010) Bárbara Maiztegui et al. CLINICAL SCIENCE
- Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: Relationship to glycemia*
- (2010) Adam M. Deane et al. CRITICAL CARE MEDICINE
- Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin: A retrospective observational pharmacy claims analysis
- (2010) R. Garg et al. DIABETES CARE
- Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years: Figure 1
- (2010) Purna Kashyap et al. GUT
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors
- (2010) A. Amato et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion
- (2010) Anne-Barbara Witte et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects
- (2009) Jing Ma et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
- (2009) J. A. Koehler et al. DIABETES
- Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes: Interactions With Metformin
- (2009) A. V. Matveyenko et al. DIABETES
- Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
- (2009) J. S. Nachnani et al. DIABETOLOGIA
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies?
- (2009) U. Beuers et al. GUT
- The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
- (2009) Rania Abu-Hamdah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia
- (2009) Adam M. Deane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- GLP-1 regulates gastroduodenal motility involving cholinergic pathways
- (2009) j. schirra et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man
- (2009) A.-B. Witte et al. REGULATORY PEPTIDES
- Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis
- (2009) Eva Tomas et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
- (2008) P. M. HELLSTRÖM et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
- (2008) Ralph A. DeFronzo et al. CURRENT MEDICAL RESEARCH AND OPINION
- Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
- (2008) M. Horowitz et al. DIABETES OBESITY & METABOLISM
- Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
- (2008) M Marzioni et al. GUT
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
- (2008) p. m. hellström et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Ileal brake: A sensible food target for appetite control. A review
- (2008) P.W.J. Maljaars et al. PHYSIOLOGY & BEHAVIOR
- Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
- (2008) Helle Linnebjerg et al. REGULATORY PEPTIDES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started